These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 21483040)

  • 1. Gerosuppressant metformin: less is more.
    Menendez JA; Cufí S; Oliveras-Ferraros C; Vellon L; Joven J; Vazquez-Martin A
    Aging (Albany NY); 2011 Apr; 3(4):348-62. PubMed ID: 21483040
    [No Abstract]   [Full Text] [Related]  

  • 2. One-carbon metabolism: an aging-cancer crossroad for the gerosuppressant metformin.
    Menendez JA; Joven J
    Aging (Albany NY); 2012 Dec; 4(12):894-8. PubMed ID: 23525940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alleviation of senescence and epithelial-mesenchymal transition in aging kidney by short-term caloric restriction and caloric restriction mimetics via modulation of AMPK/mTOR signaling.
    Dong D; Cai GY; Ning YC; Wang JC; Lv Y; Hong Q; Cui SY; Fu B; Guo YN; Chen XM
    Oncotarget; 2017 Mar; 8(10):16109-16121. PubMed ID: 28147330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin and rapamycin are master-keys for understanding the relationship between cell senescent, aging and cancer.
    Anisimov VN
    Aging (Albany NY); 2013 May; 5(5):337-8. PubMed ID: 23715473
    [No Abstract]   [Full Text] [Related]  

  • 5. Metformin and Aging: A Review.
    Glossmann HH; Lutz OMD
    Gerontology; 2019; 65(6):581-590. PubMed ID: 31522175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential anti-aging agents suppress the level of constitutive mTOR- and DNA damage- signaling.
    Halicka HD; Zhao H; Li J; Lee YS; Hsieh TC; Wu JM; Darzynkiewicz Z
    Aging (Albany NY); 2012 Dec; 4(12):952-65. PubMed ID: 23363784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New tricks from old dogs join the fight against ageing.
    Savage N
    Nature; 2017 Dec; 552(7684):S57-S59. PubMed ID: 29239380
    [No Abstract]   [Full Text] [Related]  

  • 8. Sex differences in aging, life span and spontaneous tumorigenesis in 129/Sv mice neonatally exposed to metformin.
    Anisimov VN; Popovich IG; Zabezhinski MA; Egormin PA; Yurova MN; Semenchenko AV; Tyndyk ML; Panchenko AV; Trashkov AP; Vasiliev AG; Khaitsev NV
    Cell Cycle; 2015; 14(1):46-55. PubMed ID: 25483062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aging-suppressants: cellular senescence (hyperactivation) and its pharmacologic deceleration.
    Blagosklonny MV
    Cell Cycle; 2009 Jun; 8(12):1883-7. PubMed ID: 19448395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin, aging and cancer.
    Moiseeva O; Deschênes-Simard X; Pollak M; Ferbeyre G
    Aging (Albany NY); 2013 May; 5(5):330-1. PubMed ID: 23660016
    [No Abstract]   [Full Text] [Related]  

  • 11. Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling.
    Kickstein E; Krauss S; Thornhill P; Rutschow D; Zeller R; Sharkey J; Williamson R; Fuchs M; Köhler A; Glossmann H; Schneider R; Sutherland C; Schweiger S
    Proc Natl Acad Sci U S A; 2010 Dec; 107(50):21830-5. PubMed ID: 21098287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin for aging and cancer prevention.
    Anisimov VN
    Aging (Albany NY); 2010 Nov; 2(11):760-74. PubMed ID: 21084729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperactive mTORC1 signaling is unaffected by metformin treatment in aged skeletal muscle.
    Dungan CM; Li Z; Wright DC; Williamson DL
    Muscle Nerve; 2016 Jan; 53(1):107-17. PubMed ID: 25926238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin Inhibits TGF-β1-Induced Epithelial-to-Mesenchymal Transition via PKM2 Relative-mTOR/p70s6k Signaling Pathway in Cervical Carcinoma Cells.
    Cheng K; Hao M
    Int J Mol Sci; 2016 Nov; 17(12):. PubMed ID: 27916907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hot topics in aging research: protein translation and TOR signaling, 2010.
    Kaeberlein M; Kennedy BK
    Aging Cell; 2011 Apr; 10(2):185-90. PubMed ID: 21176090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin kills and radiosensitizes cancer cells and preferentially kills cancer stem cells.
    Song CW; Lee H; Dings RP; Williams B; Powers J; Santos TD; Choi BH; Park HJ
    Sci Rep; 2012; 2():362. PubMed ID: 22500211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antidiabetic drug metformin inhibits uterine leiomyoma cell proliferation via an AMP-activated protein kinase signaling pathway.
    Li B; Takeda T; Tsuiji K; Kondo A; Kitamura M; Wong TF; Yaegashi N
    Gynecol Endocrinol; 2013 Jan; 29(1):87-90. PubMed ID: 22835064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular responses to the metal-binding properties of metformin.
    Logie L; Harthill J; Patel K; Bacon S; Hamilton DL; Macrae K; McDougall G; Wang HH; Xue L; Jiang H; Sakamoto K; Prescott AR; Rena G
    Diabetes; 2012 Jun; 61(6):1423-33. PubMed ID: 22492524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined Use of Metformin and Everolimus Is Synergistic in the Treatment of Breast Cancer Cells.
    Wang Y; Wei J; Li L; Fan C; Sun Y
    Oncol Res; 2014; 22(4):193-201. PubMed ID: 26351208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefits of Metformin in Attenuating the Hallmarks of Aging.
    Kulkarni AS; Gubbi S; Barzilai N
    Cell Metab; 2020 Jul; 32(1):15-30. PubMed ID: 32333835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.